Structural and Functional Elucidation of Yeast Lanosterol 14α-Demethylase in Complex with Agrochemical Antifungals

Autor: Matthew A. Woods, Klaus Tietjen, Mikhail V. Keniya, Jacopo Negroni, Brian C. Monk, Manya Sabherwal, Joel D. A. Tyndall, Alia A. Sagatova, Rajni K. Wilson
Jazyk: angličtina
Rok vydání: 2016
Předmět:
Azoles
0301 basic medicine
Antifungal Agents
Molecular Conformation
lcsh:Medicine
Yeast and Fungal Models
Plant Science
Pathology and Laboratory Medicine
Biochemistry
Substrate Specificity
Isomers
Sterol 14-Demethylase
chemistry.chemical_compound
Heterocyclic Compounds
Stereochemistry
Catalytic Domain
Yeasts
Medicine and Health Sciences
Stereoisomers
Post-Translational Modification
Candida albicans
lcsh:Science
Fungal Pathogens
chemistry.chemical_classification
Ergosterol
Crystallography
Multidisciplinary
Molecular Structure
biology
Organic Compounds
Antimicrobials
Physics
Lanosterol
Drugs
Condensed Matter Physics
Chemistry
14-alpha Demethylase Inhibitors
Medical Microbiology
Physical Sciences
Crystal Structure
Saccharomyces Cerevisiae
Pathogens
Agrochemicals
Protein Binding
Research Article
030106 microbiology
Plant Pathogens
Microbial Sensitivity Tests
Heme
Mycology
Research and Analysis Methods
Microbiology
Structure-Activity Relationship
Saccharomyces
03 medical and health sciences
Model Organisms
Isomerism
Microbial Control
Solid State Physics
Binding site
Microbial Pathogens
Pharmacology
Antifungals
Binding Sites
Candida glabrata
Organic Chemistry
lcsh:R
Chemical Compounds
Organisms
Fungi
Biology and Life Sciences
Proteins
Plant Pathology
biology.organism_classification
Yeast
030104 developmental biology
Enantiomers
chemistry
biology.protein
Demethylase
Azole
lcsh:Q
Zdroj: PLoS ONE, Vol 11, Iss 12, p e0167485 (2016)
PLoS ONE
ISSN: 1932-6203
Popis: Azole antifungals, known as demethylase inhibitors (DMIs), target sterol 14α-demethylase (CYP51) in the ergosterol biosynthetic pathway of fungal pathogens of both plants and humans. DMIs remain the treatment of choice in crop protection against a wide range of fungal phytopathogens that have the potential to reduce crop yields and threaten food security. We used a yeast membrane protein expression system to overexpress recombinant hexahistidine-tagged S. cerevisiae lanosterol 14α-demethylase and the Y140F or Y140H mutants of this enzyme as surrogates in order characterize interactions with DMIs. The whole-cell antifungal activity (MIC50 values) of both the R- and S-enantiomers of tebuconazole, prothioconazole (PTZ), prothioconazole-desthio, and oxo-prothioconazole (oxo-PTZ) as well as for fluquinconazole, prochloraz and a racemic mixture of difenoconazole were determined. In vitro binding studies with the affinity purified enzyme were used to show tight type II binding to the yeast enzyme for all compounds tested except PTZ and oxo-PTZ. High resolution X-ray crystal structures of ScErg11p6×His in complex with seven DMIs, including four enantiomers, reveal triazole-mediated coordination of all compounds and the specific orientation of compounds within the relatively hydrophobic binding site. Comparison with CYP51 structures from fungal pathogens including Candida albicans, Candida glabrata and Aspergillus fumigatus provides strong evidence for a highly conserved CYP51 structure including the drug binding site. The structures obtained using S. cerevisiae lanosterol 14α-demethylase in complex with these agrochemicals provide the basis for understanding the impact of mutations on azole susceptibility and a platform for the structure-directed design of the next-generation of DMIs.
Databáze: OpenAIRE